SCHEMBL5281346

SCHEMBL5281346

O=C(COCc1ccc(Cl)cc1)NCCCCCC(=O)Nc1cccc(-c2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 14/20 0.55
HDAC1 Q13547 13/20 0.55
HDAC3 O15379 11/20 0.54
HDAC4 P56524 11/20 0.54
HDAC7 Q8WUI4 11/20 0.54
HDAC2 Q92769 11/20 0.54
HDAC10 Q969S8 11/20 0.54
HDAC11 Q96DB2 11/20 0.54
HDAC8 Q9BY41 11/20 0.54
HDAC9 Q9UKV0 11/20 0.54
HDAC5 Q9UQL6 11/20 0.54
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
POLB P06746 1/20 0.47
CNR1 P21554 3/20 0.46
RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5281028 0.93 HDAC6 (0.60) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5280542 0.91 HDAC1 (0.56) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL6038060 0.90 HDAC6 (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5282785 0.90 HDAC1 (0.55) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5293057 0.90 HDAC6 (0.55) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5280854 0.90 HDAC6 (0.56) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL6038076 0.89 HDAC6 (0.54) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL6038201 0.89 HDAC6 (0.54) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5289076 0.88 HDAC6 (0.55) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5278631 0.88 HDAC6 (0.53) HDAC6HDAC1HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US claimed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 HDAC6 17/4885HDAC1 1/4885HDAC3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.